Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse

Affiliations

• ¹ Beatson West of Scotland Cancer Centre, Glasgow, UK.
• ² Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
• ³ Concord Clinical School, Concord Hospital University of Sydney, Sydney, Australia.
• ⁴ Institut Curie Hôpital René Huguenin, Saint-Cloud, France.
• ⁵ La Pitie Salpetriere Hospital, APHP-Sorbonne Universite, Paris, France.
• ⁶ Oxford University Hospitals NHS Trust, Churchill Cancer Center, Oxford, UK.
• ⁷ Nottingham University Hospitals NHS Trust, Nottingham, UK.
• ⁸ Aberdeen Royal Infirmary, Aberdeen, UK.
• ⁹ University Hospitals of Leicester NHS Trust, Leicester, UK.
• ¹⁰ University Medical Center Freiburg, Freiburg, Germany.
• ¹¹ Service des Maladies du Sang, CHU Angers, Angers, France.
• ¹² Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
• ¹³ St Vincent's Hospital Melbourne, Melbourne, Australia.
• ¹⁴ University College London Hospitals NHS Foundation Trust, London, UK.
• ¹⁵ University of Alabama, Birmingham, Alabama, USA.
• ¹⁶ Linear Clinical Research and Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
• ¹⁷ Hôpital Robert Debré CHU de Reims, Reims, France.
• ¹⁸ Liverpool University Hospitals Foundation Trust, Liverpool, UK.
• ¹⁹ Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
• ²⁰ IRCCS San Raffaele Scientific Institute, Milano, Italy.
• ²¹ Aalborg University Hospital, Aalborg, Denmark.